Obtaining Technetium-99m-Labeled Glucose Derivatives
Gardado en:
| Parent link: | Advanced Materials Research : Radiation and nuclear techniques in material science: Scientific Journal Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014).— 2015.— [P. 567-571] |
|---|---|
| Outros autores: | , , , |
| Summary: | Title screen The possibility of obtaining and using technetium-99m-labeled glucose derivatives for the diagnosis of malignant tumors by the method of single photon emission computed tomography (SPECT) has been considered. The level of international and domestic developments on this topic has been analyzed. The authors made an attempt to develop pilot batches of lyophilizates on the basis of various glucose derivatives for further obtaining appropriate radiopharmaceuticals (RPC). Режим доступа: по договору с организацией-держателем ресурса |
| Idioma: | inglés |
| Publicado: |
2015
|
| Series: | Radiation Technologies in Medicine |
| Subjects: | |
| Acceso en liña: | http://dx.doi.org/10.4028/www.scientific.net/AMR.1084.567 |
| Formato: | Electrónico Capítulo de libro |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=640463 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
| Summary: | Title screen The possibility of obtaining and using technetium-99m-labeled glucose derivatives for the diagnosis of malignant tumors by the method of single photon emission computed tomography (SPECT) has been considered. The level of international and domestic developments on this topic has been analyzed. The authors made an attempt to develop pilot batches of lyophilizates on the basis of various glucose derivatives for further obtaining appropriate radiopharmaceuticals (RPC). Режим доступа: по договору с организацией-держателем ресурса |
|---|---|
| DOI: | 10.4028/www.scientific.net/AMR.1084.567 |